[Alloy Therapeutics in Business Wire] Alloy Therapeutics and Normunity signal multi-program antibody discovery collaboration in immuno-oncology

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, a biotechnology ecosystem firm, introduced an antibody discovery collaboration spanning a number of precision immuno-oncology applications for Normunity, a biotech firm that not too long ago introduced its $65 million Collection A financing. The collaboration will assist the development of Normunity’s immune normalizers, antibody therapies designed to focus on novel mechanisms that free the physique’s regular immunity to combat most cancers, that are conceived via a novel biotech-academic collaboration with a famend immuno-oncology college analysis lab.

Learn extra  right here.